contact
 

History

Infraserv Höchst and Industriepark Höchst - the history of a company with tradition

Zeitstreifen - Permanent exhibition in the foyer of Building C 830, East Gate welcome desk
Opening hours: Monday - Thursday, 7:00 a.m. - 4:30 p.m., Friday, 7:00 a.m. - 3:00 p.m.

Zeitstreifen online: Experience industrial history

2007

Infraserv Höchst began planning a waste-to-energy plant with an annual capacity of 675,000 metric tons of refuse-derived fuel. It was designed to produce 70 megawatts of electric power and 250 metric tons of steam per hour, and to offer tenants energy at attractive, internationally competitive rates. With a project budget of € 300 million, it was the single largest investment in Industriepark Höchst's history.

Plans were also made to build a new logistics center in the southern strip of the park for around € 44 million.

2006

Industriepark Höchst, Clariant, sanofi-aventis, and Infraserv Höchst contribute to "365 Landmarks in the Land of Ideas", a nationwide lecture series.
The industrial park is one of the 365 landmarks whose activities represent Germany's innovative drive and wealth of ideas this year.

Infraserv Höchst renewed its commitment to clean, renewable energy. It opened a hydrogen filling station at Industriepark Höchst as part of the EU's Zero Regio project, and built a co-digester that could produce biogas from biosolids and organic waste.

2005

The companies in Industriepark Höchst invested over € 340 million in the site in 2005. The new facilities include a biodiesel-production plant, a purified water facility, and a Biocenter for drugs. The technologically advanced Biocenter bridges the gap between innovative research and efficient production. As such, it is a crucial building block in ensuring Industriepark Höchst's future success.

2004

Work finishes on the trimodal port on the southern bank of the Main River in Industriepark Höchst. It combines the water, rail and road transport modes - hence the name "trimodal".
Provadis' private college is also created: the School of International Management and Technology.
A functional office building is constructed on the eastern periphery of the industrial park. Owing to its unusual shape, it is dubbed the "Ship on Stilts". The state-of-the-art building brings together architectural sophistication and efficiency through innovative technology.

2003

Aventis, now called sanofi-aventis, invests a nine-figure sum in building a new insulin plant.

2001

Industriepark Höchst grows further, fuelled by the record 450 million euros invested by occupant companies. Among other projects, Infraserv Höchst builds a new multi-purpose laboratory building and a nine-story office high-rise in the south side of the park.

2000

Infraserv aligns itself with a new, process- and customer-centric structure. It sets out to lead the market as a full-service site operator.

1998

Infraserv GmbH & Co. Höchst KG is created from the site services for Hoechst AG’s parent plant. The factory site is turned into a modern, highly developed industrial park with plenty of space for new users.

1997

The former factory site is opened up to non-Hoechst companies.

1994

"Transition '94": Hoechst AG starts to reorganize and introduce a new organizational structure.

'80s

Pioneering work performed in genetic engineering. Production process for genetically engineered human insulin.

'60s/'70s

The research center in the south of the industrial park is built and expanded. Two factory bridges provide access across the Main River.

'60s

Pioneering work in environmental protection: 1965 sees the commissioning of Europe’s first large-scale biological treatment facility for industrial wastewater.

'50s

Pioneering work performed in plastics and synthetic fibers, especially the high-density polyethylene Hostalen and the polyester fiber Trevira. Oral antidiabetics are also developed.

1939

Prisoners of war, foreign workers and forced laborers from all over Europe are used during the labor shortage. Approximately nine thousand of them work at the Höchst factory.

'30s

The factory infrastructure is revamped. The generation and delivery systems for power and steam are modernized.

1923

Insulin production begins, using the process developed by Banting and Best.

1919

The Berlin architect Peter Behrens designs and builds the new Technical Administration Building for Farbwerke Hoechst. Construction starts in the spring of 1920. The engineers and office staff move into their offices in June 1924. The building is considered to be an outstanding example of expressionist architecture.

1910

Large-scale industrial production of Salvarsan, discovered by Paul Ehrlich. This syphilis drug ushers in the era of modern chemotherapy.

1894

The diphtheria serum developed by Emil von Behring enters production as the first immunobiological agent. It also launched the successful fight against diphtheria, which claimed the lives of 50,000 children per year in Germany alone.

1896

Tuberculocidin, a tuberculosis diagnostic, is Hoechst’s first immunological drug. It leads to the creation of a sero-bacteriological department.

1883

Antipyrin is the first important medicine produced industrially. It is an antipyretic and analgesic.

1869

Large-scale industrial synthesis of alizarine, the red dye made from madder and famously used in the French army's uniforms.

1863

Carl Meister, Eugen Lucius and Ludwig Müller set up a coal-tar-dye factory in Frankfurt-Höchst. The firm is manned by chemist Adolf Brüning (becomes partner in 1865), five factory workers and one office clerk. Its first product is fuchsine, a red-violet dye that earns the plant the nickname "The Red Factory".